GR35814B - Μεθοδος δια την παρασκευην διαλυματων σουλφοναμιδης και ενισχυτικης σουλφοναμιδης. - Google Patents

Μεθοδος δια την παρασκευην διαλυματων σουλφοναμιδης και ενισχυτικης σουλφοναμιδης.

Info

Publication number
GR35814B
GR35814B GR670135814A GR670135814A GR35814B GR 35814 B GR35814 B GR 35814B GR 670135814 A GR670135814 A GR 670135814A GR 670135814 A GR670135814 A GR 670135814A GR 35814 B GR35814 B GR 35814B
Authority
GR
Greece
Prior art keywords
solutions
solfonamide
sulphonamid
aids
preparation
Prior art date
Application number
GR670135814A
Other languages
Greek (el)
English (en)
Original Assignee
F. Hoffmann - La Roche & Co Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann - La Roche & Co Aktiengesellschaft filed Critical F. Hoffmann - La Roche & Co Aktiengesellschaft
Publication of GR35814B publication Critical patent/GR35814B/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electric Connection Of Electric Components To Printed Circuits (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR670135814A 1966-05-09 1967-05-08 Μεθοδος δια την παρασκευην διαλυματων σουλφοναμιδης και ενισχυτικης σουλφοναμιδης. GR35814B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH671666 1966-05-09

Publications (1)

Publication Number Publication Date
GR35814B true GR35814B (el) 1968-11-04

Family

ID=74187416

Family Applications (1)

Application Number Title Priority Date Filing Date
GR670135814A GR35814B (el) 1966-05-09 1967-05-08 Μεθοδος δια την παρασκευην διαλυματων σουλφοναμιδης και ενισχυτικης σουλφοναμιδης.

Country Status (16)

Country Link
US (1) US3551564A (cg-RX-API-DMAC7.html)
JP (1) JPS5017524B1 (cg-RX-API-DMAC7.html)
BE (1) BE698102A (cg-RX-API-DMAC7.html)
CH (1) CH544053A (cg-RX-API-DMAC7.html)
DE (1) DE1617521C3 (cg-RX-API-DMAC7.html)
DK (1) DK117520B (cg-RX-API-DMAC7.html)
ES (1) ES340262A1 (cg-RX-API-DMAC7.html)
FI (1) FI48975C (cg-RX-API-DMAC7.html)
FR (1) FR1523606A (cg-RX-API-DMAC7.html)
GB (1) GB1176395A (cg-RX-API-DMAC7.html)
GR (1) GR35814B (cg-RX-API-DMAC7.html)
IL (1) IL27876A (cg-RX-API-DMAC7.html)
IT (1) IT1143624B (cg-RX-API-DMAC7.html)
NL (1) NL140736B (cg-RX-API-DMAC7.html)
NO (1) NO127486B (cg-RX-API-DMAC7.html)
SE (1) SE348112B (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM3271A1 (en) * 1970-03-13 1972-10-23 Wellcome Found Improvements in or relating to injectable therapeutic compositions
US3728452A (en) * 1971-01-20 1973-04-17 Abic Ltd Water-soluble composition comprising sulfadimidine and pyrimethamine
IT1044231B (it) * 1972-03-16 1980-03-20 Hoffmann La Roche Combinazione di sostanze attive utile per combattere infezioni da batteri gram positivi e gran negativi
DE2342213C3 (de) * 1972-10-12 1979-10-18 F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) Verwendung von potenzierten SuIf onamiden bei der Behandlung oder Verhinderung von Fischinfektionen
US3985876A (en) * 1973-01-05 1976-10-12 Burroughs Wellcome Co. Chemotherapeutic solutions containing a sulphur and a salt of a 2,4-diamino-5-benzylpyrimidine
GB1485383A (en) * 1973-09-24 1977-09-08 Wellcome Found Injectable non-aqueous therapeutic compositions
GB1485382A (en) * 1973-09-24 1977-09-08 Wellcome Found Injectable therapeutic compositions
US4039543A (en) * 1974-12-24 1977-08-02 Hoffmann-La Roche Inc. Benzylpyrimidines
DK136934B (da) * 1976-02-06 1977-12-19 Rosco As Fremgangsmåde til fremstilling af en klar, stabil, injicerbar opløsning indeholdende et sulfonamid og en potentiator.
DE2631780C3 (de) * 1976-07-15 1981-11-19 Basf Ag, 6700 Ludwigshafen Sulfonamid-Trimethoprim-Lösungen
DE2731013C2 (de) * 1977-07-08 1982-07-15 Lentia Gmbh Verfahren zur Herstellung einer wäßrigen Infusionslösung
JPS54154775A (en) * 1978-05-24 1979-12-06 Wellcome Found Benzylpyrimidine derivative
DE2963408D1 (en) 1978-08-01 1982-09-16 Ciba Geigy Ag Stable medicinal solution on the basis of 2,6-diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimidine(trimethoprim) and a sulphonamide, process for preparing and using it
US4303643A (en) * 1979-07-05 1981-12-01 Pfizer Inc. Sulfonamide compositions
HU180740B (en) * 1979-11-27 1983-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing sulfonamide-containing,injectable pharmaceutical composition of prolongated activity
AR220263A1 (es) * 1980-02-19 1980-10-15 Bago Lab Sa Procedimiento para obtener una preparacion inyectable de sulfonamida potenciada de baja irritabilidad
CH647412A5 (de) * 1980-03-25 1985-01-31 Hoffmann La Roche Pharmazeutische praeparate.
US4374826A (en) * 1980-07-21 1983-02-22 Pfizer Inc. Sulfonamide compositions
EP4417701A4 (en) * 2021-10-12 2025-03-05 Daan Gene Co., Ltd. IN VITRO PRESERVATIVES FOR DIAGNOSTIC REAGENTS AND USE THEREOF

Also Published As

Publication number Publication date
SE348112B (cg-RX-API-DMAC7.html) 1972-08-28
FI48975C (fi) 1975-03-10
DE1617521C3 (de) 1979-09-06
DE1617521B2 (de) 1979-01-04
ES340262A1 (es) 1968-06-01
CH544053A (de) 1973-11-15
IT1143624B (it) 1986-10-22
GB1176395A (en) 1970-01-01
DE1617521A1 (de) 1972-02-10
JPS5017524B1 (cg-RX-API-DMAC7.html) 1975-06-21
BE698102A (cg-RX-API-DMAC7.html) 1967-11-08
IL27876A (en) 1971-10-20
FR1523606A (fr) 1968-05-03
US3551564A (en) 1970-12-29
NL6706474A (cg-RX-API-DMAC7.html) 1967-11-10
DK117520B (da) 1970-05-04
NL140736B (nl) 1974-01-15
FI48975B (cg-RX-API-DMAC7.html) 1974-12-02
NO127486B (cg-RX-API-DMAC7.html) 1973-07-02

Similar Documents

Publication Publication Date Title
GR35814B (el) Μεθοδος δια την παρασκευην διαλυματων σουλφοναμιδης και ενισχυτικης σουλφοναμιδης.
GR33409B (el) Τροπος παρασκευης νεων χημικων συνθεσεων και μεθοδος θεραπειας.
DK131905B (da) Analogifremgangsmåde til fremstilling af 3,1-benzoxazinderivater og syreadditionssalte deraf.
FR1513730A (fr) Procédé d'agglomération de café soluble
ES450075A1 (es) Un metodo de preparacion de derivados de bis-triazinilamino-estilbeno.
GB1128471A (en) Boomerang
GB709714A (en) Improvements relating to hypodermic needles
Savignac et al. Strength, solubility and disintegration of zinc phosphate cement with clinically determined powder-liquid ratio
ES194506A1 (es) MEJORAS INTRODUCIDAS EN LA OBTENCIoN DE PREPARADOS DE AUREOMICINA
SE397341B (sv) Forfarande for framstellning av metanol i rorugn ur vete och koloxid
FI48737C (fi) Menetelmä antineoplastisesti vaikuttavien N-/ -(6-purinyylitio)valeryy li/aminohappojen ja niiden johdannaisten valmistamiseksi.
SE7509123L (sv) 3-metylpyrazol-5-karboxylat, sett att framstella desamma och lekemedelpreparat innehallande desamma.
BG31229A3 (bg) Метод за получаване на n-(5-тетразолил)-1-оксо-1н-6-алкоксипиримидо(1,2-а)- хинолин-2-карбоксамиди
GB1060044A (en) Improvements in and relating to methods of preparing a porous surface for finishing
ES437981A1 (es) Procedimiento para la preparacion de derivados sulfonicos con estructura de polioxapolifluoroalcanos.
ES312321A1 (es) Procedimiento para la fabricacion de un preparado soluble en agua de la 3, 5 dinitro-o-toluamida
GR34334B (el) Μεθοδος δια την παρασκευην ενος νεου διθειοκαρβονικου οξεος και των αλατων αυτου.
USD148434S (en) Design for a combination compass
AU139135B2 (en) Improvements in or relating tothe preparation of guanylmelamines and. acid salts thereof
GR14096B (el) Μεθοδος παρασκευης ευδιαλυτου ενωσεως θειοφυλλινης και 3 - αμινο - μεθυλοπυριδινης.
ES120518U (es) Juego de dados recortable.
NL7514577A (nl) In water oplosbare disazokleurstoffen, bereiding en toepassing.
ES400495A1 (es) Procedimiento para la produccion de un preparado de hierro oral.
AU1592747A (en) Improvements in or relating tothe preparation of guanylmelamines and. acid salts thereof
Beighley Erythrocytic variations and liver function in rheumatic heart disease